Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Tobramycin for Bronchiectasis with Pseudomonas aeruginosa
NCT03715322Phase 3Unknown
- Sponsor
- Guangzhou Institute of Respiratory Health
- Start
- Oct 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tobramycin in bronchiectasis, Pseudomonas aeruginosa infection, sponsored by Guangzhou Institute of Respiratory Health. Status: unknown.
02
Drugs
tobramycin
03
Conditions
bronchiectasisPseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT03715322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03715322.